Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...

The Trump administration canceled $766 million in funding to drugmaker Moderna for development of a vaccine against potential ...

Moderna, Inc. (NASDAQ:MRNA) announced today that its investigational H5 avian influenza vaccine, mRNA-1018, has shown ...

The Trump administration has withdrawn $766 million allocated to Moderna Inc for developing a pandemic flu vaccine. Despite ...

The Trump administration has withdrawn $766 million in funding from Moderna, impacting the development of vaccines against ...

The department cited Moderna’s use of the messenger RNA technology, which it said “remains under-tested,” for the ...

The Trump administration canceled the grants this week, citing concerns that novel mRNA vaccine technology remains “under-tested,” posing a risk to public health.

The Trump administration has canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine ...

The Trump administration has withdrawn $766 million in funding from Moderna, impacting the development of vaccines against potential pandemic influenza viruses, including H5N1 bird flu.

The Department of Health and Human Services (HHS) is canceling hundreds of millions of dollars in funding pledged to Moderna to help the company develop, test and license mRNA-based vaccines to ...